Literature DB >> 27941880

Different in vivo and in vitro transformation of intestinal stem cells in mismatch repair deficiency.

K Keysselt1, T Kreutzmann1, K Rother1,2, C Kerner1, K Krohn3, J Przybilla2, P Buske2, H Löffler-Wirth2, M Loeffler4, J Galle2, G Aust1.   

Abstract

Mutations in mismatch repair (MMR) genes result in microsatellite instability (MSI) and early onset of colorectal cancer. To get mechanistic insights into the time scale, sequence and frequency of intestinal stem cell (ISC) transformation, we quantified MSI and growth characteristics of organoids of Msh2-deficient and control mice from birth until tumor formation and related them to tissue gene expression. Although in Msh2-deficient organoids MSI continuously increased from birth, growth characteristics remained stable at first. Months before tumor onset, normal Msh2-deficient tissue contained tumor precursor cells forming organoids with higher MSI, cystic growth and growth rates resembling temporarily those of tumor organoids. Consistently, Msh2-deficient tissue exhibited a tumor-like gene signature. Normal Msh2-deficient organoids showed increased inheritable transient cyst-like growth, which became independent of R-spondin. ISC transformation proceeded faster in vitro than in vivo independent of the underlying genotype but more under MMR deficiency. Transient cyst-like growth but not MSI was suppressed by aspirin. In summary, as highlighted by organoids, molecular alterations continuously proceeded long before tumor onset in MMR-deficient intestine, thus increasing its susceptibility for ISC transformation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27941880     DOI: 10.1038/onc.2016.429

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

Review 1.  Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications.

Authors:  Toshiro Sato; Hans Clevers
Journal:  Science       Date:  2013-06-07       Impact factor: 47.728

Review 2.  Stem cell dynamics in homeostasis and cancer of the intestine.

Authors:  Louis Vermeulen; Hugo J Snippert
Journal:  Nat Rev Cancer       Date:  2014-06-12       Impact factor: 60.716

3.  Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.

Authors:  Matthias Kloor; Cathrin Huth; Anita Y Voigt; Axel Benner; Peter Schirmacher; Magnus von Knebel Doeberitz; Hendrik Bläker
Journal:  Lancet Oncol       Date:  2012-05-01       Impact factor: 41.316

Review 4.  Milestones of Lynch syndrome: 1895-2015.

Authors:  Henry T Lynch; Carrie L Snyder; Trudy G Shaw; Christopher D Heinen; Megan P Hitchins
Journal:  Nat Rev Cancer       Date:  2015-02-12       Impact factor: 60.716

5.  MSH2 deficiency abolishes the anticancer and pro-aging activity of short telomeres.

Authors:  Paula Martinez; Irene Siegl-Cachedenier; Juana M Flores; Maria A Blasco
Journal:  Aging Cell       Date:  2009-02       Impact factor: 9.304

6.  An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents.

Authors:  Melanie H Kucherlapati; Kyeryoung Lee; Andrew A Nguyen; Alan B Clark; Harry Hou; Andrew Rosulek; Hua Li; Kan Yang; Kunhua Fan; Martin Lipkin; Roderick T Bronson; Linda Jelicks; Thomas A Kunkel; Raju Kucherlapati; Winfried Edelmann
Journal:  Gastroenterology       Date:  2009-11-18       Impact factor: 22.682

Review 7.  Molecular diagnostics in colorectal carcinoma.

Authors:  Amarpreet Bhalla; Muhammad Zulfiqar; Michael Weindel; Vinod B Shidham
Journal:  Clin Lab Med       Date:  2013-12       Impact factor: 1.935

8.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

9.  Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice.

Authors:  Benedikt Kortüm; Christoph Campregher; Michaela Lang; Vineeta Khare; Matthias Pinter; Rayko Evstatiev; Gerald Schmid; Martina Mittlböck; Theresa Scharl; Melanie H Kucherlapati; Winfried Edelmann; Christoph Gasche
Journal:  Gut       Date:  2014-11-26       Impact factor: 23.059

10.  Understanding epigenetic changes in aging stem cells--a computational model approach.

Authors:  Jens Przybilla; Thimo Rohlf; Markus Loeffler; Joerg Galle
Journal:  Aging Cell       Date:  2014-01-15       Impact factor: 9.304

View more
  5 in total

1.  Precancer Atlas to Drive Precision Prevention Trials.

Authors:  Avrum Spira; Matthew B Yurgelun; Ludmil Alexandrov; Anjana Rao; Rafael Bejar; Kornelia Polyak; Marios Giannakis; Ali Shilatifard; Olivera J Finn; Madhav Dhodapkar; Neil E Kay; Esteban Braggio; Eduardo Vilar; Sarah A Mazzilli; Timothy R Rebbeck; Judy E Garber; Victor E Velculescu; Mary L Disis; Douglas C Wallace; Scott M Lippman
Journal:  Cancer Res       Date:  2017-04-01       Impact factor: 13.312

2.  Loss of Msh2 and a single-radiation hit induce common, genome-wide, and persistent epigenetic changes in the intestine.

Authors:  Maria Herberg; Susann Siebert; Marianne Quaas; Torsten Thalheim; Karen Rother; Michelle Hussong; Janine Altmüller; Christiane Kerner; Joerg Galle; Michal R Schweiger; Gabriela Aust
Journal:  Clin Epigenetics       Date:  2019-04-27       Impact factor: 6.551

3.  Mutant Lef1 controls Gata6 in sebaceous gland development and cancer.

Authors:  Bénédicte Oulès; Emanuel Rognoni; Esther Hoste; Georgina Goss; Ryan Fiehler; Ken Natsuga; Sven Quist; Remco Mentink; Giacomo Donati; Fiona M Watt
Journal:  EMBO J       Date:  2019-03-18       Impact factor: 11.598

4.  Pro-mutagenic effects of the gut microbiota in a Lynch syndrome mouse model.

Authors:  Wietske Pieters; Floor Hugenholtz; Kevin Kos; Maxime Cammeraat; Teddy C Moliej; Daphne Kaldenbach; Sjoerd Klarenbeek; Mark Davids; Lisa Drost; Charlotte de Konink; Elly Delzenne-Goette; Karin E de Visser; Hein Te Riele
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 5.  Investigation of early neoplastic transformation and premalignant biology using genetically engineered organoid models.

Authors:  Hua Zhao; Casey Collet; Dongzi Peng; Uttam K Sinha; De-Chen Lin
Journal:  Comput Struct Biotechnol J       Date:  2022-09-21       Impact factor: 6.155

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.